Koninklijke Philips (PHIA) AGM 2026 summary

Opening remarks and agenda

• The meeting opened with acknowledgment of global geopolitical tensions and their impact on operations in over 70 countries.

• Legal and statutory requirements for the meeting were confirmed as met, with 81% of share capital represented.

• Voting was conducted electronically throughout the meeting, with shareholders able to change votes until after agenda item 9.

Financial performance review

• Solid progress was reported for 2025, including improved order intake, comparable sales growth, expanded margins, and strong cash flow.

• Disciplined cost management and productivity improvements contributed to financial results.

• Investments included over $150 million in U.S. manufacturing for AI-powered health technology.

Board and executive committee updates

• Roy Jakobs was proposed and reappointed as CEO for a four-year term, with strong support from the Supervisory Board.

• Several Supervisory Board members were reappointed, and John DeFord was appointed for his expertise in MedTech and regulatory matters.